Vonoprazan-containing therapy has an H pylori eradication rate >90% and increases eradication vs. standard triple therapy

Rashid N Lui; Francis K L Chan

doi:10.7326/ACPJ202110190-117

Vonoprazan-containing therapy has an H pylori eradication rate >90% and increases eradication vs. standard triple therapy

Ann Intern Med. 2021 Oct;174(10):JC117. doi: 10.7326/ACPJ202110190-117. Epub 2021 Oct 5.

Authors

Rashid N Lui¹, Francis K L Chan¹

Affiliation

¹ Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China (R.N.L., F.K.C.).

PMID: 34606307
DOI: 10.7326/ACPJ202110190-117

Abstract

Rokkas T, Gisbert JP, Malfertheiner P, et al. Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis. Gastroenterology. 2021;161:495-507. 33839101.

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Clarithromycin / therapeutic use
Drug Therapy, Combination
Helicobacter Infections* / drug therapy
Helicobacter pylori*
Humans
Proton Pump Inhibitors / therapeutic use
Pyrroles
Sulfonamides

Substances

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
Anti-Bacterial Agents
Proton Pump Inhibitors
Pyrroles
Sulfonamides
Clarithromycin